It is available under the brand names Mounjaro (type 2 diabetes) and Zepbound (weight loss)
They may go away on their own as your body gets used to the medication or with lifestyle modifications
TG68, a novel thyroid hormone receptor- agonist for the treatment of NAFLD
All providers exercise independent medical judgment and may prescribe, adjust, pause, or decline treatment, including GLP-1 therapies such as semaglutide and tirzepatide, based on clinical appropriateness, patient history, contraindications, and applicable state laws
While significant weight loss becomes more apparent over time as the dosages are scaled up, it is not unusual for patients to notice subtle changes in their bodies during the first week